• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复发缓解型、原发进展型和继发进展型多发性硬化症的基因表达分析。

Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis.

机构信息

Danish Multiple Sclerosis Center, Denmark.

出版信息

Mult Scler. 2013 Dec;19(14):1841-8. doi: 10.1177/1352458513500553. Epub 2013 Oct 1.

DOI:10.1177/1352458513500553
PMID:24085340
Abstract

BACKGROUND

Previous studies of multiple sclerosis (MS) have indicated differences in the pathogenesis in relapsing-remitting (RRMS), secondary progressive (SPMS) and primary progressive (PPMS) disease.

OBJECTIVE

We hypothesized that different MS subtypes would show differences in gene expression that could be traced to specific subsets of peripheral blood mononuclear cells (PBMCs).

METHODS

Gene expression in RRMS, SPMS, PPMS and healthy control (HC) PBMCs was analyzed on Affymetrix arrays. In addition, we studied gene expression in pools of purified PBMC subsets.

RESULTS

We found 380 genes that were differentially expressed in RRMS, PPMS, SPMS and HCs (false discovery rate < 5%). There were no major differences between the subtypes of MS. The genes showing most prominent expression changes in RRMS were associated with adaptive immune pathways, while genes in PPMS were associated with innate immune system pathways. SPMS patients shared pathways with RRMS and PPMS patients. Gene expression changes were most prominent in B cells, CD8+ T cells and monocytes.

CONCLUSION

Differences in gene expression, which could be traced to B cells, CD8+ T cells and monocytes, were found between MS patients and HCs but only minor differences were observed between MS subgroups.

摘要

背景

先前关于多发性硬化症(MS)的研究表明,在复发缓解型(RRMS)、继发进展型(SPMS)和原发进展型(PPMS)疾病中,其发病机制存在差异。

目的

我们假设不同的 MS 亚型会表现出基因表达的差异,这些差异可以追溯到特定的外周血单核细胞(PBMC)亚群。

方法

我们使用 Affymetrix 微阵列分析 RRMS、SPMS、PPMS 和健康对照组(HC)PBMC 的基因表达。此外,我们还研究了 PBMC 亚群的纯化池中的基因表达。

结果

我们发现了 380 个在 RRMS、PPMS、SPMS 和 HCs 中差异表达的基因(错误发现率 < 5%)。MS 各亚型之间没有明显差异。RRMS 中表达变化最明显的基因与适应性免疫途径有关,而 PPMS 中的基因与固有免疫系统途径有关。SPMS 患者与 RRMS 和 PPMS 患者共享途径。基因表达变化在 B 细胞、CD8+T 细胞和单核细胞中最为明显。

结论

MS 患者与 HC 之间存在 B 细胞、CD8+T 细胞和单核细胞等基因表达的差异,但在 MS 亚组之间观察到的差异较小。

相似文献

1
Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis.复发缓解型、原发进展型和继发进展型多发性硬化症的基因表达分析。
Mult Scler. 2013 Dec;19(14):1841-8. doi: 10.1177/1352458513500553. Epub 2013 Oct 1.
2
Genetic differences between primary progressive and relapsing-remitting multiple sclerosis: The impact of immune-related genes variability.原发性进行性和复发缓解型多发性硬化症之间的遗传差异:免疫相关基因变异性的影响。
Mult Scler Relat Disord. 2019 Apr;29:130-136. doi: 10.1016/j.msard.2019.01.033. Epub 2019 Jan 24.
3
Global transcriptome profiling of mild relapsing-remitting versus primary progressive multiple sclerosis.轻度复发缓解型与原发性进展型多发性硬化症的全球转录组谱分析。
Eur J Neurol. 2018 Apr;25(4):651-658. doi: 10.1111/ene.13565. Epub 2018 Feb 13.
4
Serious infections in patients with relapsing and progressive forms of multiple sclerosis: A German claims data study.复发型和进展型多发性硬化症患者的严重感染:一项德国索赔数据研究。
Mult Scler Relat Disord. 2022 Dec;68:104245. doi: 10.1016/j.msard.2022.104245. Epub 2022 Oct 17.
5
Multiple sclerosis by phenotype in Germany.德国基于表型的多发性硬化症。
Mult Scler Relat Disord. 2022 Jan;57:103326. doi: 10.1016/j.msard.2021.103326. Epub 2021 Oct 10.
6
Whole transcriptome analysis of multiple Sclerosis patients reveals active inflammatory profile in relapsing patients and downregulation of neurological repair pathways in secondary progressive cases.对多发性硬化症患者的全转录组分析显示,复发型患者存在活跃的炎症特征,而继发进展型患者的神经修复途径下调。
Mult Scler Relat Disord. 2020 Sep;44:102243. doi: 10.1016/j.msard.2020.102243. Epub 2020 Jun 4.
7
Specific alterations in NKG2D T lymphocytes in relapsing-remitting and progressive multiple sclerosis patients.复发缓解型和进展型多发性硬化症患者 NKG2D T 淋巴细胞的特异性改变。
Mult Scler Relat Disord. 2023 Mar;71:104542. doi: 10.1016/j.msard.2023.104542. Epub 2023 Jan 26.
8
Increased socioeconomic burden in patients with primary progressive multiple sclerosis: A Danish nationwide population-based study.原发性进行性多发性硬化症患者社会经济负担加重:一项基于丹麦全国人口的研究。
Mult Scler Relat Disord. 2020 Nov;46:102567. doi: 10.1016/j.msard.2020.102567. Epub 2020 Oct 10.
9
Profile of Polish patients with primary progressive multiple sclerosis.波兰原发性进行性多发性硬化症患者的特征。
Mult Scler Relat Disord. 2019 Aug;33:33-38. doi: 10.1016/j.msard.2019.05.009. Epub 2019 May 21.
10
Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis.基因表达和基因分型研究表明,白细胞介素7受体与原发性进展型多发性硬化症的发病机制有关。
J Mol Med (Berl). 2005 Oct;83(10):822-30. doi: 10.1007/s00109-005-0684-y. Epub 2005 Aug 2.

引用本文的文献

1
Auranofin Modulates Thioredoxin Reductase/Nrf2 Signaling in Peripheral Immune Cells and the CNS in a Mouse Model of Relapsing-Remitting EAE.金诺芬在复发缓解型实验性自身免疫性脑脊髓炎小鼠模型中调节外周免疫细胞和中枢神经系统中的硫氧还蛋白还原酶/Nrf2信号通路。
Biomedicines. 2023 Sep 10;11(9):2502. doi: 10.3390/biomedicines11092502.
2
Effects of Ibudilast on Retinal Atrophy in Progressive Multiple Sclerosis Subtypes: Post Hoc Analyses of the SPRINT-MS Trial.依达拉奉对进展型多发性硬化亚型中视网膜萎缩的影响:SPRINT-MS 试验的事后分析。
Neurology. 2023 Sep 5;101(10):e1014-e1024. doi: 10.1212/WNL.0000000000207551. Epub 2023 Jul 17.
3
Methylation and Gene Expression in Relation to the Multiple Sclerosis-Associated Gene Variant rs2104286 and Soluble IL-2Rα in CD8 T Cells.
甲基化与基因表达与多发性硬化症相关基因变异 rs2104286 及 CD8 T 细胞中可溶性 IL-2Rα 的关系
Front Immunol. 2021 Jul 27;12:676141. doi: 10.3389/fimmu.2021.676141. eCollection 2021.
4
Pharmacological Inhibition of STAT3 by Stattic Ameliorates Clinical Symptoms and Reduces Autoinflammation in Myeloid, Lymphoid, and Neuronal Tissue Compartments in Relapsing-Remitting Model of Experimental Autoimmune Encephalomyelitis in SJL/J Mice.Stattic对信号转导和转录激活因子3(STAT3)的药理抑制作用可改善SJL/J小鼠实验性自身免疫性脑脊髓炎复发缓解模型中骨髓、淋巴和神经组织区室的临床症状并减轻自身炎症反应。
Pharmaceutics. 2021 Jun 22;13(7):925. doi: 10.3390/pharmaceutics13070925.
5
A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis.活动期多发性硬化症中的致病性和克隆扩增 B 细胞转录组。
Proc Natl Acad Sci U S A. 2020 Sep 15;117(37):22932-22943. doi: 10.1073/pnas.2008523117. Epub 2020 Aug 28.
6
Engineered immunological niches to monitor disease activity and treatment efficacy in relapsing multiple sclerosis.工程化免疫微环境以监测复发型多发性硬化症的疾病活动和治疗效果。
Nat Commun. 2020 Aug 3;11(1):3871. doi: 10.1038/s41467-020-17629-z.
7
STAT3 signaling in myeloid cells promotes pathogenic myelin-specific T cell differentiation and autoimmune demyelination.STAT3 信号在髓样细胞中促进致病性髓鞘特异性 T 细胞分化和自身免疫性脱髓鞘。
Proc Natl Acad Sci U S A. 2020 Mar 10;117(10):5430-5441. doi: 10.1073/pnas.1913997117. Epub 2020 Feb 24.
8
The Putative Association of TOB1-AS1 Long Non-coding RNA with Immune Tolerance: A Study on Multiple Sclerosis Patients.长链非编码 RNA TOB1-AS1 与免疫耐受的假定关联:多发性硬化症患者的研究。
Neuromolecular Med. 2020 Mar;22(1):100-110. doi: 10.1007/s12017-019-08567-1. Epub 2019 Sep 3.
9
Mononuclear cell transcriptome changes associated with dimethyl fumarate in MS.与富马酸二甲酯相关的多发性硬化症单核细胞转录组变化
Neurol Neuroimmunol Neuroinflamm. 2018 Jun 12;5(4):e470. doi: 10.1212/NXI.0000000000000470. eCollection 2018 Jul.
10
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis.多发性硬化症患者颈内静脉壁表达谱和血浆蛋白水平的变化。
Mol Med. 2018 Aug 9;24(1):42. doi: 10.1186/s10020-018-0043-4.